- Home
- AXSM vs IESC Comparison
AXSM vs IESC Comparison
Compare AXSM & IESC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | IESC |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 13.2B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AXSM | IESC |
|---|---|---|
| Price | $241.00 | $626.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | $211.12 | ★ $458.00 |
| AVG Volume (30 Days) | ★ 845.0K | 267.3K |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.56 | ★ 51.87 |
| EPS | N/A | ★ 9.95 |
| Revenue | N/A | ★ $3,371,468,000.00 |
| Revenue This Year | $57.24 | $22.20 |
| Revenue Next Year | $55.88 | $14.88 |
| P/E Ratio | ★ N/A | $66.70 |
| Revenue Growth | N/A | ★ 16.89 |
| 52 Week Low | $96.09 | $309.51 |
| 52 Week High | $260.19 | $804.00 |
Technical Indicators
Market Signals| Indicator | AXSM | IESC |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 44.69 |
| Support Level | $236.44 | $591.89 |
| Resistance Level | $256.40 | $700.20 |
| Average True Range (ATR) | 9.57 | 34.32 |
| MACD | -0.26 | 2.20 |
| Stochastic Oscillator | 56.90 | 42.78 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About IESC IES Holdings Inc.
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.